Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Cardiovalve logo — Pioneering a new era in mitral valve replacement with a tran...

Cardiovalve

Pioneering a new era in mitral valve replacement with a transfemoral delivery system designed for enhanced safety and minimal cardiac interference.

Founded 2017 51-200 employees Biotechnology, Health Care +1

General Information

Company Name Cardiovalve
Founded Year 2017
Employees 51-200
Industries Biotechnology, Health Care, Medical Devices
Social

Get notified when Cardiovalve moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cardiovalve

Cardiovalve is a pioneering medical device company that is focused on developing a transfemoral mitral valve replacement system. The company's slogan, "Pioneering a new era in mitral valve replacement with a transfemoral delivery system designed for enhanced safety and minimal cardiac interference," aptly captures its innovative approach. Specifically, the Cardiovalve system is meticulously crafted to replace the mitral valve via a transfemoral technique, utilizing femoral venous access. This method offers several notable advantages, including a compact profile that minimizes intrusion into the left ventricle, thereby reducing disruption to cardiac blood flow and enhancing safety. Founded in 2017, Cardiovalve operates within the Biotechnology, Health Care, and Medical Devices industries. Currently, the company is engaging in clinical studies to assess the safety and performance of its system, with plans to seek approval in the EU and US. Although specific details regarding the company's headquartered location and its last investment are not available at this time, Cardiovalve's focused dedication to advancing cardiovascular treatment through innovative medical devices positions it as a promising venture for potential investors seeking opportunities within the medical technology sector.

Taxonomy: medical device company, transfemoral delivery, mitral valve replacement, cardiac intervention, clinical studies, EU approval, US approval, transseptal delivery, femoral venous access, cardiac blood flow, safety assessment, performance evaluation, left ventricle, minimal intrusion, innovative medical technology

No funding data available for Cardiovalve yet.

Get notified when Cardiovalve raises funding

Cardiovalve Alternatives & Competitors

Cardiovalve vs
NeoChord, Inc.
NeoChord, Inc. United States

Transforming Mitral Valve Repair

Convertible Note
20 employees
Biotechnology, Health Care
Cardiovalve vs
InnovHeart
InnovHeart Italy

Art of Innovation, Innovation to the Heart

Series C
30 employees
Manufacturing, Medical Devices
Cardiovalve vs
HVR Cardio Oy
HVR Cardio Oy Finland

HVR Cardio is a medical device company focused on developing first-generation transcatheter mitral v...

Series B
12 employees
Health Care

FAQ About Cardiovalve

Pioneering a new era in mitral valve replacement with a transfemoral delivery system designed for enhanced safety and minimal cardiac interference.
Cardiovalve was founded in 2017.
Cardiovalve operates in the following industries: Biotechnology, Health Care, Medical Devices.
Cardiovalve has approximately 51-200 employees.
Top alternatives and competitors to Cardiovalve include NeoChord, Inc., InnovHeart, HVR Cardio Oy, Evalve, Mitralign Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cardiovalve and NeoChord, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cardiovalve and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy